Examples of anti-IL-6 monoclonal antibodies are tocilizumab, commonly used in autoimmune disease showing a better survival in cachexia mice, and clazakizumab, which demonstrated improved symptoms such as fatigue and weight loss [133]. This evidence concerns the gene IL6 and Cachexia.